What's new

[Cyprus Times] Indian company's cough syrup may be linked to deaths of dozens of children in Gambia, WHO says

siropidg.jpg
[/QUOTE]
WHO warning to remove the company's products from the market They may have been distributed elsewhere

The deaths of dozens of children in The Gambia from kidney damage may be linked to contaminated cough and cold syrups made by an Indian drug maker, the World Health Organization said today.

WHO Director-General, Tedros Adanom Gebrejesus, told reporters that the UN agency is conducting an investigation along with Indian regulators and New Delhi-based pharmaceutical company Maiden Pharmaceuticals Ltd.

Maiden Pharma declined to comment on the warning issued by the WHO, while Reuters calls and messages to India's drug controller general went unanswered. The Gambian government and India's health ministry also did not immediately respond to a request for comment.

The WHO also issued a medical product warning asking regulators to remove Maiden Pharma's products from the market.

The products may have been distributed elsewhere through unofficial purchases, but so far they have only been identified in The Gambia, the WHO said in its warning.

The warning concerns four products Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup.

Laboratory analysis confirmed "unacceptable" amounts of diethylene glycol and ethylene glycol, which can be toxic when consumed, the WHO said.

[BR][BR]

The Gambian government said last month it was also investigating the deaths as an increase in cases of acute kidney injury in children under the age of five was recorded at the end of July.

Doctors in The Gambia raised the alarm in July after several children began falling ill with kidney function problems three to five days after taking a topical paracetamol syrup. By August, 28 had died, but health authorities said the toll was likely to rise. Now the death toll stands at 66, the WHO said today.

The deaths have shaken the small West African nation, which is already facing multiple health emergencies, which include measles and malaria.

Maiden Pharmaceuticals produces drugs at its facility in India, which it then sells domestically and exports to countries in Asia, Africa and Latin America, according to its website.

Πηγή APE-MPE


Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top